Menu
GeneBe

MAP4K4

mitogen-activated protein kinase kinase kinase kinase 4, the group of Mitogen-activated protein kinase kinase kinase kinases

Basic information

Region (hg38): 2:101696849-101894690

Links

ENSG00000071054NCBI:9448OMIM:604666HGNC:6866Uniprot:O95819AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MAP4K4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP4K4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
3
clinvar
5
missense
2
clinvar
48
clinvar
1
clinvar
51
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
2
3
non coding
40
clinvar
40
Total 0 3 49 3 43

Variants in MAP4K4

This is a list of pathogenic ClinVar variants found in the MAP4K4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-101697473-C-T Benign (May 13, 2021)1240597
2-101697716-A-ACT Benign (May 28, 2021)1225314
2-101697929-C-CCCG Benign (May 20, 2021)1238946
2-101697975-T-C Benign (May 12, 2021)1259880
2-101698111-G-A Inborn genetic diseases Uncertain significance (Mar 01, 2024)3123121
2-101698135-CG-C Uncertain significance (Mar 17, 2023)2443781
2-101698156-G-A Benign (May 16, 2021)1183785
2-101698171-G-GGGCAGCC Benign (May 13, 2021)1231613
2-101698174-CA-C Benign (May 13, 2021)1221787
2-101698300-C-T Benign (May 20, 2021)1283903
2-101698483-G-C Uncertain significance (Jan 24, 2022)2573809
2-101698520-C-CT Uncertain significance (Mar 24, 2023)2580529
2-101698595-A-G Benign (May 12, 2021)1243012
2-101790572-A-G Benign (May 14, 2021)1231427
2-101790717-C-T not specified Likely benign (Jan 09, 2018)514744
2-101790727-A-T Uncertain significance (Dec 07, 2023)3252352
2-101790736-C-T Inborn genetic diseases Uncertain significance (Aug 16, 2021)2245455
2-101790948-C-T Benign (May 13, 2021)1281319
2-101823704-G-A Benign (May 13, 2021)1269539
2-101824002-T-C Likely benign (Dec 31, 2019)711192
2-101824261-G-A Benign (May 13, 2021)1279855
2-101829343-T-G Benign (May 13, 2021)1259339
2-101829431-A-G Benign (May 14, 2021)1183615
2-101829522-A-G Inborn genetic diseases Uncertain significance (Dec 14, 2021)2267409
2-101829544-A-G Inborn genetic diseases Uncertain significance (Mar 29, 2023)2531587

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MAP4K4protein_codingprotein_codingENST00000347699 30197838
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.10e-71246440121246560.0000481
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.743206640.4820.00003698035
Missense in Polyphen105235.050.446722791
Synonymous0.7552292440.9390.00001342344
Loss of Function7.29775.30.09300.00000445857

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001250.000124
Ashkenazi Jewish0.00009930.0000993
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00005330.0000531
Middle Eastern0.000.00
South Asian0.00003840.0000327
Other0.0001660.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322. {ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:9890973}.;
Pathway
MAPK signaling pathway - Homo sapiens (human);EGF-Core;Oxidative Stress Induced Senescence;MAPK Signaling Pathway;Angiopoietin Like Protein 8 Regulatory Pathway;Insulin Signaling;double stranded rna induced gene expression;cd40l signaling pathway;signal transduction through il1r;tnf/stress related signaling;nf-kb signaling pathway;nfkb activation by nontypeable hemophilus influenzae;keratinocyte differentiation;mapkinase signaling pathway;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;ceramide signaling pathway;Cellular responses to external stimuli;Direct p53 effectors;TNF receptor signaling pathway ;EPHB forward signaling;Ceramide signaling pathway (Consensus)

Recessive Scores

pRec
0.226

Intolerance Scores

loftool
0.258
rvis_EVS
-1.44
rvis_percentile_EVS
3.95

Haploinsufficiency Scores

pHI
0.515
hipred
Y
hipred_score
0.786
ghis
0.579

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.961

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Map4k4
Phenotype
embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
map4k4
Affected structure
gastrulation
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
MAPK cascade;negative regulation of cell-matrix adhesion;protein phosphorylation;signal transduction by protein phosphorylation;microvillus assembly;positive regulation of cell migration;stress-activated protein kinase signaling cascade;positive regulation of ARF protein signal transduction;activation of protein kinase activity;intracellular signal transduction;negative regulation of apoptotic process;positive regulation of GTPase activity;regulation of JNK cascade;neuron projection morphogenesis;positive regulation of keratinocyte migration;positive regulation of focal adhesion assembly;negative regulation of insulin secretion involved in cellular response to glucose stimulus;negative regulation of neuron projection regeneration;positive regulation of adherens junction organization
Cellular component
cytoplasm;focal adhesion
Molecular function
creatine kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;microtubule binding